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Japan's population is aging more rapidly than that of any other country. Frailty has recently been
recognized as an important priority. Understanding the basic epidemiology of frailty in Japan, which is an
example of a rapidly aging society, will be beneﬁcial for Japan as well as other countries expecting an
aging population. A systematic literature search of 11 electronic databases was conducted in March 2016
using a comprehensive set of Medical Subject Heading and text terms for any studies published in 2000
or later that report the prevalence of frailty among Japanese community-dwelling older people aged 65
years or older. A total of 1529 studies were identiﬁed in the systematic search, of which ﬁve studies were
included in this review. The pooled prevalence of frailty, prefrailty, and robustness was 7.4% (95% con-
ﬁdence interval [CI], 6.1%e9.0%), 48.1% (95% CI, 41.6%e54.8%), and 44.4% (95% CI, 37.2%e51.7%), respec-
tively. A signiﬁcant degree of heterogeneity was observed. There was no evidence of publication bias.
Age-stratiﬁed meta-analyses of four studies showed the pooled prevalence of frailty was 1.9%, 3.8%,
10.0%, 20.4%, and 35.1% for those aged 65e69, 70e74, 75e79, 80e84, and 85 years, respectively. Pooled
prevalence of frailty was 8.1% for women and 7.6% for men. This review showed an overall pooled
prevalence of frailty among Japanese community-dwelling older people of 7.4%. The age-stratiﬁed
analysis suggested that Japanese older people are less frail before their late 70's but frailer in later life
than older people in other countries. These ﬁndings provide important basic information for all parties
involved in Japanese frailty research.
© 2016 The Authors. Publishing services by Elsevier B.V. on behalf of The Japan Epidemiological
Association. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Because Japan has the world's highest life expectancy and a
persistently low birth rate, Japan's population is aging more rapidly
than that of any other country.1 The proportion of people aged 65
years and older was approximately 10% in 1985. This proportion
doubled to 21% in 2007, making Japan a hyper-aged society.2,3 The
latest governmental provisional estimates report that as much as
26.7% of the Japanese population were over 65 years old in 2015.4
This rate is much higher than in other developed countries: 17%
in the United Kingdom,14% in the United States, 9% in China, 21% inare and Population Health,
nd Hill Street, London, NW3
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.008Germany, 19% in France, 22% in Italy, and 16% in Canada.3 By 2060,
Japan is expected to far exceed the current understanding of a
hyper-aged society, when 40% of the entire population will be aged
65 years or over.5 With the increasing number of older people in
Japan, there is expected to be a substantial increase in health care
and social security costs.
The Japanese government has already begun to prepare for this
challenging issue.6 It has started to attempt to adapt society in
order to maximize older people's health and to facilitate healthy
aging via maintaining their functional capacity and preventing
disability and dependence.7 One of the campaign targets is frailty.8
Frailty is a state of vulnerability to poor resolution of homeostasis
when exposed to a stressor event as a consequence of age-related
cumulative deﬁcits across multiple physiological systems.9 It is
considered a pre-disability state and is associated with various
negative health outcomes, including falls, hospitalization,n Epidemiological Association. This is an open access article under the CC BY-NC-ND
pan: A systematic review andmeta-analysis, Journal of Epidemiology
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life, and mortality.9e16 The most widely used deﬁnition of frailty is
the frailty phenotype proposed by Fried et al. using data from the
Cardiovascular Health Study.17 They recognized frailty as a distinct
clinical syndrome using a set of ﬁve physical phenotypic compo-
nents: unintentional weight loss, exhaustion, weakness, slow
walking speed, and low physical activity with an underlying bio-
logical basis.17 In the Fried criteria, an individual is classiﬁed as frail,
prefrail, and robust when they meet 3, 1e2, and 0 of the com-
ponents, respectively.17
Given the detrimental physical and psychological impact of
frailty on older people, as well as its potential reversibility,18,19
frailty may be a promising target of interventions.9 Frail older
people, who are not highly ﬁt but not completely disabled, are the
population likely to beneﬁt most from such interventions.20 In this
regard, frailty can be an important outcome, for which it is worth
exploring the modiﬁable risk factors or predictors to be addressed
for prevention.21 Therefore, understanding the basic epidemiology
of frailty in older people is essential for clinicians, researchers, and
policymakers to further pursue frailty research and support.22,23
According to previous systematic reviews,24,25 the prevalence of
frailty based on the Fried criteria among community-dwelling
people aged 65 years and older ranged from 4% in a United States
study26 to 27.3% in a Spanish study.27 One of these reviews per-
formed ameta-analysis using data from 15 studies and showed that
the weighted prevalence of physical frailty was 9.9%.24
In other selected populations, the prevalence of frailty has been
reported to be much higher, such as in patients with cancer (range,
6e28%; based on the Fried criteria)28 and nursing home patients
(pooled prevalence 46.9%; 95% conﬁdence interval [CI], 27.7%e
66.6%; based on the Fried criteria).29 Japanese studies were not
included in the aforementioned reviews, and the evidence
regarding the prevalence of frailty among the Japanese population
is scarce in the literature. Understanding the current frailty status in
Japan as an example of a rapidly aging society will be beneﬁcial for
research and health policy for Japan as well as any other countries
experiencing rapid population aging.
The purposes of this systematic review and meta-analysis study
were two-fold: to systematically search the literature for available
evidence on the prevalence of physical frailty among Japanese
community-dwelling older people, and to conduct a meta-analysis
to synthesize the pooled prevalence of frailty.
In general, people become frailer with age and females are more
likely to be frailer than their male counterparts.24 However, since
Japan is unique in its longevity,30 universal health insurance sys-
tem, healthy Japanese food, enhanced awareness about healthy
aging among the general public, and the so-called Japanese
smoking paradox (Japanese people smoke more but develop less
lung cancer than people in Western countries), Japanese people
may have different courses and patterns of frailty status than other
populations. In addition, merely pooling the prevalence of frailty
without taking into consideration the cohort characteristics, such
as mean age or female proportion, may obscure important sub-
group differences. Therefore, we also performed meta-analyses
stratiﬁed according to age and gender.2. Methods
2.1. Protocol
A protocol was developed according to the Preferred Reporting
Items for Systematic Review and Meta-Analysis (PRISMA) state-
ment31 and has been published elsewhere.32Please cite this article in press as: Kojima G, et al., Prevalence of frailty in Ja
(2016), http://dx.doi.org/10.1016/j.je.2016.09.0082.2. Data sources and search strategy
A systematic search of the literature was conducted in March
2015 for studies published in 2000 or later by two investigators (GK
and YT) using ten electronic databases: Scopus, Web of Science,
Embase, MEDLINE, LILACS, CINAHL Plus, PsycINFO, Cochrane Li-
brary, AMED, and ICHUSHI Web, with explosion function if avail-
able and without language restriction. The search terms used for
the databases, except those for ICHUSHI Web, are as follows:
[(Frailty) OR (Frailty syndrome (Medical Subject Heading (MeSH)))]
AND [(Japan*) OR (Japan (MeSH))]. ICHUSHI Web is a Japanese
bibliographic database containing mainly Japanese articles and
both English and Japanese terms can be used for searching. The
search terms for ICHUSHI Web included (Frailty) and Japanese
MeSH and text terms corresponding to frailty, and the studies were
limited to original articles involving people aged 65 years or older,
excluding case reports or case series. Other data sources included
the manual search of bibliographies of the relevant articles, per-
sonal inquiries to experts in this ﬁeld, and a search of another
Japanese electronic database, Japan Science and Technology Infor-
mation Aggregator, Electronic (J-STAGE), using a search strategy
similar to the one for ICHUSHI Web. Corresponding and/or last
authors were contacted for additional data necessary for a meta-
analysis. Ethics approval was not required, as this study did not
involve human subjects.
2.3. Study selection and methodological quality assessment
Any studies providing or potentially capable of providing cross-
sectional data regarding prevalence of frailty status deﬁned using
the Fried criteria or its modiﬁed versions among Japanese
community-dwelling people aged 65 years and older in Japanwere
eligible. Studies were excluded if they used selected samples, such
as peoplewith certain diseases or conditions, or were a randomized
controlled trial, review article, editorial, or comment. Gray litera-
ture, such as conference abstracts, was also considered. When
multiple studies used the same cohort, the study with the largest
sample size was included. A clinician researcher with an internal
medicine and geriatric medicine background (GK) assessed the
identiﬁed studies via screening titles, abstracts, and full texts. The
studies considered as eligible were further assessed for methodo-
logical quality using six items from a tool for critically appraising
studies of prevalence or incidence of a health problem developed
by Loney et al.33 Studies meeting three or more of the six items
were considered to have adequatemethodological quality andwere
included in the meta-analysis.
2.4. Data extraction
The data collected directly from the included studies or pro-
vided by the authors upon request were ﬁrst author's name, cohort
name if any, publication year, prefecture where the participants
were recruited from, sample size, age (mean and range), proportion
of female participants, percentage and the number of participants
according to frailty categories (frail, prefrail, and robust), and cohort
characteristics.
2.5. Statistical analysis
The numbers of the entire cohort, as well as those classiﬁed
frail, prefrail, and robust, were used for analysis. Heterogeneity
across the studies was assessed using Cochran's Q test, and het-
erogeneity was considered to be present when p < 0.05. The de-
gree of heterogeneity was assessed using the I2 statistic. The I2
values of 25%, 50%, and 75% were considered as low, moderate,pan: A systematic review andmeta-analysis, Journal of Epidemiology
G. Kojima et al. / Journal of Epidemiology xxx (2016) 1e7 3and high degrees of heterogeneity, respectively.34 Pooled preva-
lence and 95% CIs of frailty, prefrailty, and robustness were
calculated using a random-effects model if heterogeneity was
present and a ﬁxed-effects model if heterogeneity was absent.
Publication bias was assessed using Begg-Mazumdar's35 and
Egger's36 tests and visually inspecting the funnel plots. All sta-
tistical analyses were completed using StatsDirect (ver. 2.8,
StatsDirect, Cheshire, UK) and p < 0.05 was considered statisti-
cally signiﬁcant.3. Results
3.1. Selection processes
The systematic search of the literature using ten electronic da-
tabases identiﬁed 1521 citations, and eight additional citations
were found through other sources. Of these 1529 citations, 443
were duplicates and were removed, and 1058 citations were
excluded through title and abstract screening. Twenty eight studies
were left for full-text review, of which 23 studies were excluded
because they used the same cohort (n ¼ 11), used a method other
than the Fried criteria to deﬁne frailty (n ¼ 10), or used a selected
sample (n ¼ 2), leaving ﬁve included studies. The methodological1,521 studies identified via database searching
Scopus (n=158)
Web of Science (n=158)
Embase (n=155)
MEDLINE (n=91)
LILACS (n=83)
CINAHL Plus (n=33)
PsycINFO (n=14)
Cochrane Library (n=2)
AMED (n=1)
ICHUSHI Web (n=826)
1,086 studies screened for titles and a
28 articles for full-text review
Total of 1,529 studies identifie
5 studies included for methodologica
assessment
5 studies included for meta-analy
Fig. 1. PRISMA
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(2016), http://dx.doi.org/10.1016/j.je.2016.09.008quality of the ﬁve studies was assessed and considered to be
adequate for meta-analysis (Fig. 1).3.2. Study characteristics
The characteristics of the ﬁve included studies are summarized
in Table 1. Four studies37e40 were published as journal articles, and
one study41 was presented as a poster at a scientiﬁc meeting. All
studies were published in 2011 or later. Two studies39,41 were
conducted in prefectures around or near Tokyo (Gunma, Ibaraki,
Chiba, and Fukushima Prefectures). The other studies37,38,40 were
from more western areas (Fukuoka, Aichi, and Kyoto Prefectures).
Sample sizes ranged from 48340 to 8864.38 Mean age was similar
among four studies at 73.3e74.3 years,37,38,40,41 and one study did
not report the mean age or age range.39 While one study included
only female participants,41 the remaining studies were mixed, with
approximately 50e70% females.37e40 No studies used cohorts of a
nationally representative elderly population. Three studies37e39
used locally representative cohorts and two used samples origi-
nally recruited at health events.40,41 Exclusion criteria were pro-
vided in three studies,37,38,40 which excluded individuals with
disability,38,40 neurological and cognitive disorders,37,38,40 or those
using long-term care services.37,38,408 additional studies identified through 
other sources
bstracts
d
443 duplicated studies excluded
1,058 studies excluded via title and 
abstract screening
l quality 
23 studies excluded via full-text review
Same cohort (n=11)
Non-Fried criteria (n=10)
Selected sample (=2)
sis
ﬂow chart.
pan: A systematic review andmeta-analysis, Journal of Epidemiology
Table 1
Summary of study characteristics and overall prevalence of frailty status among Japanese community-dwelling older people in Japana.
Author/Study Year Prefecture Sample
size
Age
(range)
Female
(%)
Frail Prefrail Robust Quality
score
Cohort characteristics
Shirooka et al. 2016 Kyoto 483 73.3
(65e92)
68.3% 8.3% (40) 65.2% (315) 26.5% (128) 4/6 - Health event
- Exclusion criteria: in long-term care
service, ADL disability, severe cardiac,
pulmonary, neurological, and
musculoskeletal disorders, dementia
Chen et al. Sasaguri
Genkimon Study
2015 Fukuoka 1565 73.3
(65e93)
60.1% 9.5%
(149)
43.9% (687) 46.6% (729) 5/6 - Population-based study
- Exclusion criteria: in long-term care
service, dementia, Parkinson's dis-
ease, depression
Shimada et al.
NCGG-SGS
2015 Aichi 8864 73.4
(65e96)
52.0% 8.4%
(743)
51.0%
(4517)
40.7%
(3604)
5/6 - Population-based study
- Exclusion criteria: in long-term care
service, ADL disability, Parkinson's
disease, stroke, depression, dementia,
MMSE < 21
Shinkai et al. Kusatsu
longitudinal study
2013 Gunma 526  (65) e 5.7% (30) 38.0% (200) 56.3% (296) 4/6 - Population-based study
- Exclusion criteria: not documented
Seino et al. 2011 Ibaraki,
Chiba,
Fukushima
502 74.3
(65e92)
100% 4.6% (23) 42.7% (214) 52.8% (265) 4/6 - Health event
- Exclusion criteria: not documented
NCGG-SGS, National Center for Geriatrics and Gerontology-Study of Geriatric Syndromes.
a All studies used modiﬁed Cardiovascular Health Study frailty criteria.
G. Kojima et al. / Journal of Epidemiology xxx (2016) 1e743.3. Prevalence of frailty
Data from ﬁve studies were available for meta-analysis of the
prevalence of frailty status. The prevalence of frailty, prefrailty, and
robustness in individual studies ranged 4.6%e9.5%, 38.0%e65.2%,
and 26.5%e56.3%, respectively. Since signiﬁcant degrees of het-
erogeneity were observed across the studies for the three frailty
categorizations (I2 ¼ 79.2%e97.1%, all p < 0.001), random-effects
models were used. The pooled prevalences of frailty, prefrailty,
and robustness were 7.4% (95% CI, 6.1%e9.0%), 48.1% (95% CI, 41.6%e
54.8%), and 44.4% (95% CI, 37.2%e51.7%), respectively (Fig. 2). There
was no evidence of publication bias according to Begg-Mazumdar's
and Egger's tests (all p > 0.05) and visual inspection of the funnel
plots (not shown).3.4. Stratiﬁed analysis
Additional data were obtained upon request from the authors of
four studies37,38,40,41 and were used for meta-analysis stratiﬁed by
age, gender, and both. The pooled prevalence of frailty in ﬁve age
groups (65e69, 70e74, 75e79, 80e84, and85 years old) was 1.9%,
3.8%, 10.0%, 20.4%, and 35.1%, respectively (Fig. 3). As one study41
included only women, four studies37,38,40,41 were used for strati-
ﬁed meta-analysis for women, while three studies37,38,40 were used
for men. The pooled prevalence of frailty was 8.1% for women and
7.6% for men (Fig. 3). When stratiﬁed by both age group and gender,
prevalence of frailty increased with age in men and women. More
women were frail than men in most age groups, except for 70e74
years old (Table 2).3.4.1. Changes in heterogeneity
A high degree of heterogeneity persisted among women
(I2 ¼ 81.8%, p < 0.001) and the younger three age groups: 65e69,
70e74, and 75e79 years (I2 ¼ 68.6%e81.1%, all p < 0.05), while the
heterogeneity decreased to non-signiﬁcant levels among men
(I2 ¼ 42.4%, p ¼ 0.18) and in the older two age groups: 80e84
and 85 years old (I2¼ 0%e54.2%, all p> 0.05), which suggests that
the high heterogeneity may be partially explained via variations in
gender and age.Please cite this article in press as: Kojima G, et al., Prevalence of frailty in Ja
(2016), http://dx.doi.org/10.1016/j.je.2016.09.0084. Discussion
This systematic review and meta-analysis identiﬁed ﬁve studies
incorporating 11,940 Japanese people aged 65 years or older living
in the community and demonstrated that the pooled prevalences of
frailty, prefrailty, and robustness based on the Fried criteria were
7.4%, 48.1%, and 44.4%, respectively. Stratiﬁed analyses showed that
women were frailer than men and that prevalence of frailty
increased with age.
Two previous systematic reviews24,25 reported the prevalence of
frailty in multinational community-dwelling elderly populations,
and one24 of these further performed meta-analysis. Our review
included only Japanese older people, and it showed some distinc-
tive and notable ﬁndings compared with these previous reviews.
First, the range of frailty prevalence reported by the included
studies (4.6e9.5%) was much narrower than that of previous re-
views (4.0e17.0%24 and 4.9e27.3%,25 both based on the Fried
criteria). This can be explained by the fact that the current review
included only Japanese older people in Japan, while the previous
reviews included cohorts from multiple different countries;
therefore, there may have been less between-individual and
between-study variations in the prevalence of frailty in our review
than in the previous ones. Another possible explanation is that the
included cohorts were similar in terms of age because themean age
and age range of the cohorts were fairly close (mean age ranged
from 73.3 to 74.3 years, and included age ranges were nearly
identical) (Table 1). Second, our pooled prevalence of frailty based
on the Fried criteria (7.5%; 95% CI, 6.1%e9.0%) was lower than
weighted prevalence of physically-deﬁned frailty by Collard et al.
(9.9%; 95% CI, 9.6%e10.2%).24 Among the studies included in our
review, some recruited participants from health events40,41 or a
health check-up39 or excluded those with activities of daily living
(ADL) disability,38,40 which may have contributed to a lower pooled
prevalence of frailty than that of the general elderly population. It
should be noted that our review and that of Collard et al.24 used
different statistical methodologies and included studies using
different frailty criteria. Third, stratiﬁed meta-analyses were per-
formed to further examine the pooled prevalence of frailty ac-
cording to age and gender. The result of the gender-stratiﬁed
analysis showing that women were frailer than men was not sur-
prising and was in line with previous reports.24 As also expected,pan: A systematic review andmeta-analysis, Journal of Epidemiology
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Proportion meta-analysis plot [random effects]
0.02 0.04 0.06 0.08 0.10 0.12
combined 0.07 (0.06, 0.09)
Seino 2011 0.05 (0.03, 0.07)
Shinkai 2013 0.06 (0.04, 0.08)
Shimada 2015 0.08 (0.08, 0.09)
Chen 2015 0.10 (0.08, 0.11)
Shirooka 2016 0.08 (0.06, 0.11)
proportion (95% confidence interval)
Proportion meta-analysis plot [random effects]
0.3 0.4 0.5 0.6 0.7
combined 0.48 (0.42, 0.55)
Seino 2011 0.43 (0.38, 0.47)
Shinkai 2013 0.38 (0.34, 0.42)
Shimada 2015 0.51 (0.50, 0.52)
Chen 2015 0.44 (0.41, 0.46)
Shirooka 2016 0.65 (0.61, 0.69)
proportion (95% confidence interval)
Proportion meta-analysis plot [random effects]
0.2 0.4 0.6 0.8
combined 0.44 (0.37, 0.52)
Seino 2011 0.53 (0.48, 0.57)
Shinkai 2013 0.56 (0.52, 0.61)
Shimada 2015 0.41 (0.40, 0.42)
Chen 2015 0.47 (0.44, 0.49)
Shirooka 2016 0.27 (0.23, 0.31)
proportion (95% confidence interval)
Fig. 2. Forest plots of prevalence of (A) frailty, (B) prefrailty, and (C) robustness among
Japanese community-dwelling older people in Japan.
G. Kojima et al. / Journal of Epidemiology xxx (2016) 1e7 5
Please cite this article in press as: Kojima G, et al., Prevalence of frailty in Ja
(2016), http://dx.doi.org/10.1016/j.je.2016.09.008the age-stratiﬁed analysis showed that the prevalence of frailty
increased steadily with age. In a previous review,24 age-stratiﬁed
weighted prevalence of frailty (based on any frailty deﬁnition)
among community-dwelling older people from multiple countries
was approximately 4% in those aged 65e69 years; 7% in those aged
70e74 years; 10% in those aged 75e79 years; 16% in those aged
80e84 years; and 26% in those aged 85 years. Compared with
these ﬁndings, our review showed that the younger two age groups
had lower prevalence (1.9% in those aged 65e69 years and 3.8% in
those aged 70e74 years), the 75e79-year age group had the same
prevalence (10.0%), and older age groups had higher prevalence
(20.4% in those aged 80e84 years and 35.1% in those aged 85
years). The reasons why the prevalence of frailty was lower in the
young elderly and higher in the older elderly in our study are not
clear. One possibility, given the high life expectancy among Japa-
nese, is that non-Japanese frail older people die early, which leads
to lower prevalence of frailty in later years due to the heathy sur-
vivor effect,42 while Japanese frail older people survive longer,
which leads to higher prevalence of frailty in their 80's and later.
Further research regarding the impact of environmental factors and
ethnic background on frailty status and progression may be helpful
to elucidate this discrepancy.
There are two tools that have been developed and used in Japan
for identifying vulnerable older adults with high risks not specif-
ically for frailty but for general adverse health outcomes, such as
dependency, disability, or institutionalization.
The Kihon Checklist (KCL) is a self-reported comprehensive
questionnaire consisting of 25 simple questions covering multiple
domains of instrumental ADL, physical function, oral function,
nutrition, cognition, social activity, and depressive mood. The
checklist was originally developed by the Japanese Ministry of
Health, Labour and Welfare in 2005e2006, when the long-term
care insurance system, which had originally been started in 2000,
was reformed to focus more on prevention.43 This questionnaire
has been widely used in Japanese local municipal ofﬁces and cen-
ters as an initial screening tool to identify at-risk older individuals
and, if necessary, initiate interventional programs and facilitate
various governmental long-term care and support services ac-
cording to their conditions. This tool was validated as a screening
tool for frailty and shown to have good-to-excellent accuracy: the
area under the receiver operating characteristic curve (AUC) to
predict frailty (deﬁned by the Fried criteria) was 0.92 in a sample of
geriatric outpatients with chronic diseases44 and 0.88 in a sample
of community-dwelling older people.45 One study involving 14,636
Japanese elderly aged 65 years or older identiﬁed 38.0% as frail
based on the KCL; frail participants were signiﬁcantly more likely to
be newly certiﬁed for long-term-care insurance over 1 year than
those who were non-frail (OR 3.80; 95% CI, 3.02e4.78).46
Another tool is the Frailty Index for Japanese elderly (FI-J), also
known as the Kaigo-Yobo Checklist, which is a 15-item question-
naire to identify older adults at high risk of becoming dependent or
in need of long-term care.47 This index has also been validated for
frailty screening in a population-based study, with good accuracy to
predict Fried criteria-deﬁned frailty (AUC ¼ 0.89), and frailty
deﬁned by this index was a signiﬁcant predictor of incident difﬁ-
culties in ADL (OR 3.42; 95% CI, 1.79e6.54 over 4 years), incident
long-term-care certiﬁcation (HR 3.50; 95% CI, 2.41e5.07 over 5
years), and mortality (HR 2.43; 95% CI, 1.70e3.47 over 5 years) in-
dependent of age, gender, and presence of comorbidity.39
These feasible self-report questionnaires are easy to implement
and have potential as frailty screening tools covering multidimen-
sional components. Now that both have been shown to identify,
with good-to-excellent accuracy, Fried-deﬁned frail older people,pan: A systematic review andmeta-analysis, Journal of Epidemiology
Fig. 3. Forest plots of prevalence of frailty stratiﬁed by age groups and gender.
G. Kojima et al. / Journal of Epidemiology xxx (2016) 1e76future research can be designed to compare their abilities to predict
important outcomes, such as mortality or the long-term-care need,
with other widely used frailty criteria, or to use these tools as a
continuous index similar to the Rockwood Frailty Index,48 instead
of the two-group dichotomization (frailty vs. non-frailty), in order
to make the most of the nature as a continuous score to evaluate
and capture frailty status in a graded manner. These attempts may
lead to the discovery of the best frailty measure suitable for Japa-
nese community-dwelling older people.
The ﬁndings of the current review need to be interpreted with
caution. First, the pooled prevalence of frailty synthesized from
the included studies may be smaller than the true prevalence. As
mentioned earlier, some of the included studies recruited older
people at health events40,41 or a municipal annual health check-
up,39 and some studies excluded those with ADL disability.38,40
Therefore, the population included in the meta-analysis may be
more health conscious and/or less disabled, possibly resulting in a
pooled prevalence of frailty lower than that of general older
population in Japan. Despite this possibility, the age-stratiﬁed
meta-analyses suggest that prevalence of frailty is not neces-
sarily lower in all age groups compared with other countries'
populations: Japanese people aged 80 years or older are frailer
than their international counterparts (Fig. 3 and a previous re-
view24). Second, all studies included in the meta-analysis deﬁned
frailty using not the original version of the Fried criteria but ver-
sions with some modiﬁcations to some or all of the ﬁve compo-
nents, apparently due to data availability. One example is that,
while Fried et al. originally deﬁned slow gait speed as being in the
slowest 20% of usual walking speed stratiﬁed by gender and
height, Shirooka et al. and Shimada et al. deﬁned slow gait speedTable 2
Prevalence of frailty stratiﬁed by age groups and gender.
Age group, years Women Men
Prevalence 95% CI Prevalence 95% CI
65e69 2.1% 0.7e4.3% 1.8% 1.2e2.6%
70e74 3.8% 1.7e6.6% 4.2% 3.3e5.1%
75e79 10.1% 5.9e15.1% 7.7% 1.7e17.6%
80e84 22.3% 19.3e25.4% 18.1% 15.1e21.3%
85 37.2% 31.1e43.6% 32.3% 25.8e39.3%
CI, conﬁdence interval.
Please cite this article in press as: Kojima G, et al., Prevalence of frailty in Ja
(2016), http://dx.doi.org/10.1016/j.je.2016.09.008as a walking speed of less than 1.0 m/s. These modiﬁcations may
have inﬂuenced the ﬁndings.49 Third, a high degree of heteroge-
neity was observed across the studies included in the meta-
analysis (I2 ¼ 79.2%, p < 0.001). This may be due to the effects of
age distribution and/or gender proportion of the cohorts, since
additional analyses stratifying the cohorts by age and gender
alleviated the degree of heterogeneity in some groups. Fourth, a
limited number of studies were included in this review, and the
sample sizes of the studies were relatively small. Future research
should include more studies with larger cohorts, especially for the
oldest participants (85 years or older).
A major strength of this review is the robust methodology: the
literature was comprehensively searched using 11 electronic data-
bases; the identiﬁed studies were screened with standardized
processes and assessed for heterogeneity, methodological quality,
and publication bias; meta-analyses were repeated with stratiﬁ-
cation by age and gender. This review is the ﬁrst to provide pooled
evidence on the prevalence of frailty status among Japanese
community-dwelling older people, and the ﬁndings are valuable
and beneﬁcial for clinicians, researchers, and policymakers. This
information will help clinicians to treat older patients appropri-
ately, stratifying the risks and life courses based on their frailty
status. The overall prevalence of frailty among Japanese older
people in the community is fundamental information for re-
searchers and can be used to design population-based studies or
randomized controlled trials, or to investigate pathophysiology or
predictors of frailty. Policymakers may also use the information to
effectively distribute limited health care resources and to translate
the research ﬁndings into planning healthcare services.
In summary, this review has shown that the pooled prevalences
of frailty, prefrailty, and robustness among Japanese community-
dwelling older people were 7.5%, 48.1%, and 44.4%, respectively.
These ﬁndings provide important basic information for all parties
involved in Japanese frailty research. The age-stratiﬁed analysis
showed the possibility that Japanese older people are less frail
before their late 70's but frailer in later life than older people in
other countries.Conﬂicts of interest
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